山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 64-70.doi: 10.6040/j.issn.1671-7554.0.2021.0076
张明明1,高伟1,崔佳1,霍丽静1,胡晴川1,李伟皓2,王超3
ZHANG Mingming1, GAO Wei1, CUI Jia1, HUO Lijing1, HU Qingchuan1, LI Weihao2, WANG Chao3
摘要: 目的 探讨微小RNA-33a(miR-33a)在稳定型心绞痛患者血清中水平及检测价值。 方法 选取2018年1月至2019年12月确诊的稳定型心绞痛患者220例(心绞痛组),选取同期健康体检者200例(对照组)。心绞痛组按疾病严重程度分为Ⅰ、Ⅱ、Ⅲ、Ⅳ级。应用实时定量PCR法检测两组血清miR-33a表达水平;同时检测两组血清的血脂和炎性因子水平。采用GEO数据库检索数据,对miR-33a的功能进行生物信息学分析。 结果 心绞痛组血清miR-33a水平明显高于对照组(P<0.05)。不同分级的心绞痛患者血清miR-33a水平差异有统计学意义(P<0.05)。心绞痛组血脂指标中血清中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白、极低密度脂蛋白水平高于对照组,而高密度脂蛋白水平则低于对照组(P<0.05)。心绞痛组血清炎性因子指标中肿瘤坏死因子(TNF-α)、高敏C-反应蛋白(hsCRP)、白细胞介素-6(IL-6)的水平高于对照组。心绞痛组血清miR-33a与低密度脂蛋白、极低密度脂蛋白均呈正相关,与高密度脂蛋白呈负相关(P<0.05)。心绞痛组血清miR-33a水平与TNF-α、IL-6呈正相关(P<0.05)。生物信息学分析显示,miR-33a具有调控一些转录组基因的功能,参与核酸代谢、信号传导、细胞生长、氨基酸转运等过程。 结论 miR-33a在稳定型心绞痛患者血清中存在表达增高现象,与一些血脂及炎性因子指标有相关性,miR-33a可能通过较为复杂的分子网络机制调控各项指标在稳定型心绞痛的病情进展中发挥作用。
中图分类号:
[1] Xuan JW, Huang M, Lu YJ, et al. Economic evaluation of safflower yellow injection for the treatment of patients with stable angina pectoris in China: a cost-effectiveness analysis[J]. J Altern Complementary Med N Y N Y, 2018, 24(6): 564-569. [2] Yang M, Du T, Sun M, et al. Acupuncture for stable angina pectoris: a systematic review protocol[J]. BMJ Open, 2018, 8(4): e019798. [3] Long L, Anderson L, Dewhirst AM, et al. Exercise-based cardiac rehabilitation for adults with stable angina[J]. Cochrane Database Syst Rev, 2018, 2: CD012786. doi:10.1002/14651858.cd012786.pub2. [4] Rosano GMC, Vitale C, Volterrani M. Pharmacological management of chronic stable angina: focus on ranolazine[J]. Cardiovasc Drugs Ther, 2016, 30(4): 393-398. [5] Buhagiar A, Borg J, Ayers D. Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions[J]. Noncoding RNA Res, 2020, 5(1): 22-26. [6] Munteanu VC, Munteanu RA, Onaciu A, et al. MiRNA-Based inspired approach in diagnosis of prostate cancer [J]. Medicina(Kaunas), 2020, 56(2): 94. [7] Zhu T, Corraze G, Plagnes-Juan E, et al. Cholesterol metabolism regulation mediated by SREBP-2, LXRα and miR-33a in rainbow trout(Oncorhynchus mykiss)both in vivo and in vitro[J]. PLoS One, 2020, 15(2): e0223813. doi:10.1371/journal.pone.0223813. [8] Karimi-Sales E, Jeddi S, Ebrahimi-Kalan A, et al. Trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways[J]. Food Funct, 2018, 9(8): 4292-4298. [9] Zhang Q, Ai Y, Dong H, et al. Circulating oxidized low-density lipoprotein is a strong risk factor for the early stage of coronary heart disease[J]. IUBMB Life, 2019, 71(2): 277-282. [10] Duman H, Özyıldız AG, Bahçeci I, et al. Serum visfatin level is associated with complexity of coronary artery disease in patients with stable angina pectoris[J]. Ther Adv Cardiovasc Dis, 2019, 13: 1753944719880448. doi:10.1177/1753944719880448. [11] 葛均波, 徐永健, 王辰. 内科学[M]. 9版. 北京: 人民卫生出版社, 2018: 224. [12] Liu HH, Cao YX, Sun D, et al. High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes[J]. Hypertens Res, 2019, 42(11): 1783-1793. [13] Su J, Wu FB, Xia HP, et al. Accurate cancer cell identification and microRNA silencing induced therapy using tailored DNA tetrahedron nanostructures[J]. Chem Sci, 2020, 11(1): 80-86. [14] Shi L, Zhu H, Shen Y, et al. Regulation of E2F transcription factor 3 by microRNA-152 modulates gastric cancer invasion and metastasis[J]. Cancer Manag Res, 2020, 12: 1187-1197. doi:10.2147/cmar.s239752. [15] Thanikachalam PV, Ramamurthy S, Wong ZW, et al. Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future[J]. Drug Discov Today, 2018, 23(3): 460-480. [16] Liu G, Liu W, Guo J. Clinical significance of miR-181a in patients with neonatal sepsis and its regulatory role in the lipopolysaccharide-induced inflammatory response [J]. Exp Ther Med, 2020, 19(3):1977-1983. [17] Pan JC, Fang S, Tian HH, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling[J]. Mol Cancer, 2020, 19(1): 9. [18] Jiang K, Sun F, Zhu J, et al. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression[J]. Mol Genet Genomic Med, 2019, 7(8): e833. [19] Price NL, Rotllan N, Canfrán-Duque A, et al. Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis[J]. Cell Rep, 2017, 21(5): 1317-1330. [20] Erhartova D, Cahova M, Dankova H, et al. Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation[J]. PLoS One, 2019, 14(11): e0224820. doi:10.1371/journal.pone.0224820. [21] Zhu L, Lu Z, Zhu L, et al. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people[J]. Kardiol Pol, 2015, 73(10): 931-938. [22] Deng X, Qin S, Chen Y, et al. B-RCA revealed circulating miR-33a/b associates with serum cholesterol in type 2 diabetes patients at high risk of ASCVD[J]. Diabetes Res Clin Pract, 2018, 140: 191-199. doi:10.1016/j.diabres.2018.03.024. [23] Dlouha D, Blaha M, Blaha V, et al. Analysis of circulating miRNAs in patients with familial hypercholesterolaemia treated by LDL/Lp(a)apheresis[J]. Atheroscler Suppl, 2017, 30: 128-134. doi:10.1016/j.atherosclerosissup.2017.05.037. [24] Rayner KJ, Fernandez-Hernando C, Moore KJ. MicroRNAs regulating lipid metabolism in atherogenesis[J]. Thromb Haemost, 2012, 107(4): 642-647. [25] Shah B, Newman JD, Woolf K, et al. Anti-inflammatory effects of a vegan diet versus the American heart association-recommended diet in coronary artery disease trial[J]. J Am Heart Assoc, 2018, 7(23): e011367. [26] Guo Q, Zhang H, Zhang B, et al. Tumor Necrosis Factor-alpha(TNF-α)Enhances miR-155-Mediated Endothelial Senescence by Targeting Sirtuin1(SIRT1)[J]. Med Sci Monit, 2019, 25:8820-8835. doi: 10.12659/MSM.919721. [27] Held C, White HD, Stewart RAH, et al. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY(Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy)Trial [J]. J Am Heart Assoc, 2017, 6(10): e005077. [28] Zhong Y, Liu C, Feng J, et al. Curcumin affects ox-LDL-induced IL-6, TNF-alpha, MCP-1 secretion and cholesterol efflux in THP-1 cells by suppressing the TLR4/NF-kappaB/miR33a signaling pathway [J]. Exp Ther Med, 2020, 20(3):1856-1870. |
[1] | 龙宇晗,罗霞,姜洁. 妊娠期异常高脂血症2例报告并文献复习[J]. 山东大学学报 (医学版), 2021, 59(3): 103-106. |
[2] | 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31. |
[3] | 李明卓,孙秀彬,王春霞,杨洋,刘新辉,刘言训,薛付忠,袁中尚. 血脂正常人群HDL-C纵向变化与冠心病的关联性分析:一项回顾性队列研究[J]. 山东大学学报 (医学版), 2019, 57(8): 110-116. |
[4] | 耿二冬,宁涓. 阿替洛尔对急性冠脉综合征合并心律失常患者的临床疗效及预后影响[J]. 山东大学学报 (医学版), 2018, 56(5): 70-73. |
[5] | 王美建,侯新国,梁凯,陈丽. 山东省城市中老年人群血脂现状调查[J]. 山东大学学报(医学版), 2017, 55(5): 70-75. |
[6] | 张琳,李敬,王泽,张江涛,马增香,石玉华. 多囊卵巢综合征患者促甲状腺激素对血糖、血脂的影响[J]. 山东大学学报(医学版), 2017, 55(1): 80-84. |
[7] | 马琳,张冬,唐蕾,叶嗣源,焉传祝,曹丽丽. 肌萎缩侧索硬化预后相关的血液学标志物[J]. 山东大学学报(医学版), 2016, 54(4): 46-50. |
[8] | 杨淑娟, 苏士利, 董白桦. 20例阴道内放置NuvaRing避孕环后微环境的改变[J]. 山东大学学报(医学版), 2015, 53(7): 58-60. |
[9] | 张蓬, 岳龙涛, 李亨, 张民, 王聪聪, 段瑞生, 窦迎春. 血脂康对实验性自身免疫性神经炎的治疗潜能[J]. 山东大学学报(医学版), 2015, 53(2): 1-5. |
[10] | 谌红珊, 陈垚, 刘晟忻, 冯建, 赵长峰, 于连龙, 任慈, 黄斯妤. 水摄入及其他膳食因素对血脂异常人群的影响[J]. 山东大学学报(医学版), 2015, 53(1): 81-86. |
[11] | 魏颖, 孙雅文, 高优美, 薛付忠, 于红霞, 张成琪. 济南市部分职业女性膳食模式与超重、血压、血糖和血脂异常的关系[J]. 山东大学学报(医学版), 2014, 52(8): 102-107. |
[12] | 张洁1,2,周聊生1,史浩3,梁英1,高海青4. 血脂及其相关性剩留风险对老年人颈动脉斑块组份及稳定性的影响[J]. 山东大学学报(医学版), 2013, 51(4): 1-5. |
[13] | 周雁1,郭立新1,周璐2,汪耀1,牟忠卿1,王晓霞1,于冬妮1,张丽娜11,周璐2,汪耀1,牟忠卿1,王晓霞1,于冬妮1,张丽娜1. 老年2型糖尿病患者周围神经病变的影响因素[J]. 山东大学学报(医学版), 2012, 50(6): 1-4. |
[14] | 唐振旺. 不稳定型心绞痛介入治疗后基质金属蛋白酶9的表达改变对预后的影响[J]. 山东大学学报(医学版), 2012, 50(2): 120-. |
[15] | 李秀芹1,2,3,卜培莉1,2. 血浆网膜素-1和白介素-18水平与冠心病的关系[J]. 山东大学学报(医学版), 2012, 50(10): 86-89. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 265
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 1116
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Cited |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Shared | ||||||||||||||||||||||||||||||||||||||||||||||||||
Discussed |
|